by Elena Iemma | Jun 7, 2022
A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
by Elena Iemma | Sep 10, 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation